• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography.

作者信息

Garabedian H D, Gold H K, Yasuda T, Johns J A, Finkelstein D M, Gaivin R J, Cobbaert C, Leinbach R C, Collen D

机构信息

Cardiac Division, Massachusetts General Hospital, Boston 02114.

出版信息

J Am Coll Cardiol. 1988 Apr;11(4):729-34. doi: 10.1016/0735-1097(88)90204-5.

DOI:10.1016/0735-1097(88)90204-5
PMID:3127451
Abstract

Increases in plasma creatine kinase-MB (MB CK) were correlated with the onset of coronary artery reperfusion determined angiographically in 32 patients with acute myocardial infarction who were treated with recombinant human tissue-type plasminogen activator (rt-PA). Reperfusion occurred in 14 (70%) of 20 patients with left anterior descending coronary artery occlusion and in 8 (73%) of 11 patients with right coronary artery occlusion. One patient had persistent left circumflex coronary artery occlusion. Plasma MB CK levels (radioimmunometric assay) did not increase significantly in patients with persistent occlusion, but increased by a mean (+/- SEM) of 8 +/- 1 and 6 +/- 1 times over pretreatment levels at the end of the infusion in patients with a reperfused left anterior descending and right coronary artery, respectively. When a greater than or equal to 2.5-fold increase in MB CK levels at the end of the rt-PA infusion was taken as evidence of reperfusion of the left anterior descending coronary artery, 13 (93%) of 14 patients with reperfusion and 5 (83%) of 6 with persistent occlusion were correctly identified. When a greater than or equal to 2.2-fold increase in MB CK levels was used to identify right coronary artery reperfusion, seven (89%) of eight patients with persistent occlusion were correctly identified. The sensitivity and specificity of these indexes, derived from and applied to the same patient group, were 91 and 89%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography.
J Am Coll Cardiol. 1988 Apr;11(4):729-34. doi: 10.1016/0735-1097(88)90204-5.
2
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.基于血清肌酸激酶同工酶MB变化及临床变量的溶栓后再灌注无创检测。心肌梗死溶栓与血管成形术7研究组(TAMI 7研究组)。
Am Heart J. 1993 Oct;126(4):819-26. doi: 10.1016/0002-8703(93)90694-5.
3
Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
J Am Coll Cardiol. 1995 Sep;26(3):662-7. doi: 10.1016/0735-1097(95)00210-U.
4
Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction.早期冠状动脉再灌注可减弱急性心肌梗死中纤溶酶原激活物抑制剂-1和血管性血友病因子的促凝反应。
J Am Coll Cardiol. 1990 Dec;16(7):1553-60. doi: 10.1016/0735-1097(90)90300-e.
5
[Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].[血清肌红蛋白浓度作为急性心肌梗死患者溶栓治疗后再灌注的早期标志物]
Pol Merkur Lekarski. 1997 Sep;3(15):109-12.
6
Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve.利用肌酸激酶同工酶(CK-MB)时间-活性曲线特征评估急性心肌梗死患者的再灌注指标。
Am Heart J. 1991 Aug;122(2):400-8. doi: 10.1016/0002-8703(91)90992-q.
7
[Evaluation of clinical criteria of coronary artery recanalization in acute myocardial infarction].[急性心肌梗死冠状动脉再通临床标准的评估]
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Jun;19(3):139-42, 196.
8
Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis.
J Am Coll Cardiol. 1991 Aug;18(2):613-20. doi: 10.1016/0735-1097(91)90621-f.
9
Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction.肌酸激酶峰值作为急性心肌梗死溶栓治疗有效性的一项指标。
Am J Cardiol. 1987 Jun 1;59(15):1234-8. doi: 10.1016/0002-9149(87)90896-4.
10
Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms.基于肌酸激酶同工酶MB亚基血浆活性的急性心肌梗死再灌注无创检测
J Am Coll Cardiol. 1991 Apr;17(5):1047-52. doi: 10.1016/0735-1097(91)90828-w.

引用本文的文献

1
CK-MB Kinetics as a Superior Prognostic Indicator in Primary PCI: Moving Beyond TIMI Flow Grade 3.CK-MB动力学作为直接PCI中一项更优的预后指标:超越TIMI血流3级
JACC Asia. 2025 May;5(5):660-662. doi: 10.1016/j.jacasi.2025.02.004. Epub 2025 Apr 15.
2
Evaluation of coronary artery patency using cardiac markers.使用心脏标志物评估冠状动脉通畅情况。
J Thromb Thrombolysis. 2005 Feb;19(1):21-4. doi: 10.1007/s11239-005-0936-2.
3
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
利用血浆中脂肪酸结合蛋白浓度评估心肌梗死患者的冠状动脉再灌注情况。
Heart. 2001 Mar;85(3):278-85. doi: 10.1136/heart.85.3.278.
4
Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion.早期、完全梗死血管再通:达成心肌再灌注未来临床研究的金标准。
J Thromb Thrombolysis. 1997;4(2):259-266. doi: 10.1023/a:1008899002382.
5
ECG monitoring, biochemical Testing, and Anticoagulation Assessment.心电图监测、生化检测及抗凝评估。
J Thromb Thrombolysis. 1996;3(3):263-269. doi: 10.1007/BF00181671.
6
Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.溶栓治疗后动脉通畅性的无创诊断及其与预后的关系。
Br Heart J. 1993 Jun;69(6):485-91. doi: 10.1136/hrt.69.6.485.
7
Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.
Cardiovasc Drugs Ther. 1993 Nov;7(5):809-16. doi: 10.1007/BF00878935.
8
Biochemical markers of myocardial necrosis in acute myocardial infarction and thrombolysis.
Ann Hematol. 1994 Oct;69(4):S59-63. doi: 10.1007/BF02215959.
9
Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction.急性心肌梗死溶栓治疗后五种心脏标志物在再灌注检测中的比较。
Br Heart J. 1995 May;73(5):422-7. doi: 10.1136/hrt.73.5.422.
10
Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction.脂质过氧化产物的短暂释放作为心肌梗死溶栓成功后再灌注的无创标志物。
Br Heart J. 1995 Mar;73(3):223-6. doi: 10.1136/hrt.73.3.223.